Oversight of hormone compounding
Executive Summary
American Medical Association House of Delegates requests Nov. 14 that FDA review the formulations of all compounded bioidentical hormone formulations. "Since the final hormone formulations of most compounding pharmacies are not subject to FDA monitoring for dose, purity, safety, or efficacy, there may be additional, and at this point unknown, risks associated with them," AMA says. Association is also asking FDA to require adverse event monitoring and patient information for bioidentical formulations. Medco recently stopped dispensing compounded estrogen, and Wyeth is pressing FDA to block pharmacists from producing the products (1"The Pink Sheet" Oct. 9, 2006, In Brief)...
You may also be interested in...
Medco mail-order drops hormones
Medco's mail order pharmacy will cease dispensing compounded estrogen, testosterone and progestin products. In a letter to physicians acknowledging that "the practice of extemporaneous compounding remains controversial," the pharmacy benefit manager asks doctors to consider switching patients to an FDA-approved product. The firm cites claims from physician groups that compounded hormones have not been proven to be more safe or effective than marketed products. FDA is reviewing a Wyeth citizen petition requesting the agency stop pharmacists from compounding bioidentical HRTs (1"The Pink Sheet" Nov. 7, 2005, p. 11)...
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.